Chavdoula et al., 2019 - Google Patents
CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulationChavdoula et al., 2019
View PDF- Document ID
- 13378075169574958569
- Author
- Chavdoula E
- Habiel D
- Roupakia E
- Markopoulos G
- Vasilaki E
- Kokkalis A
- Polyzos A
- Boleti H
- Thanos D
- Klinakis A
- Kolettas E
- Marcu K
- Publication year
- Publication venue
- Life science alliance
External Links
Snippet
Through the progressive accumulation of genetic and epigenetic alterations in cellular physiology, non–small-cell lung cancer (NSCLC) evolves in distinct steps involving mutually exclusive oncogenic mutations in K-Ras or EGFR along with inactivating mutations in the …
- 210000004072 Lung 0 title abstract description 100
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Karreth et al. | The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo | |
| Belgardt et al. | The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes | |
| Badie et al. | BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping | |
| Mudhasani et al. | Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells | |
| Winslow et al. | Suppression of lung adenocarcinoma progression by Nkx2-1 | |
| Dickins et al. | Tissue-specific and reversible RNA interference in transgenic mice | |
| Chavdoula et al. | CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation | |
| Rasmussen et al. | Smyd1 facilitates heart development by antagonizing oxidative and ER stress responses | |
| US20150283101A1 (en) | Identification of rnai targets and use of rnai for rational therapy of chemotherapy-resistant leukemia and other cancers | |
| Moser et al. | MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency | |
| Senner et al. | Disruption of a conserved region of Xist exon 1 impairs Xist RNA localisation and X-linked gene silencing during random and imprinted X chromosome inactivation | |
| WO2016061073A1 (en) | Composition and method for in vivo engineering of chromosomal rearrangements | |
| Zimmerman et al. | Oct4/Sox2 binding sites contribute to maintaining hypomethylation of the maternal igf2/h19 imprinting control region | |
| Teoh et al. | Maspin is not required for embryonic development or tumour suppression | |
| Ciampricotti et al. | Rlf–mycl gene fusion drives tumorigenesis and metastasis in a mouse model of small cell lung cancer | |
| Lee et al. | Esrp1-regulated splicing of Arhgef11 isoforms is required for epithelial tight junction integrity | |
| Cao et al. | Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene | |
| Chow et al. | Group I Paks are essential for epithelial-mesenchymal transition in an Apc-driven model of colorectal cancer | |
| Yue et al. | CRISPR/Cas9-mediated modulation of splicing efficiency reveals short splicing isoform of Xist RNA is sufficient to induce X-chromosome inactivation | |
| Mircetic et al. | Development of a genetic sensor that eliminates p53 deficient cells | |
| WO2017048995A1 (en) | Inducible crispr/cas9 and rnai systems and methods of use | |
| Huang et al. | Decreased tumorigenesis in mice with a Kras point mutation at C118 | |
| Kondo et al. | Cross-species RNAi rescue platform in Drosophila melanogaster | |
| Rodriguez et al. | Versatile and enhanced tumour modelling in mice via somatic cell transduction | |
| Ko et al. | A versatile single-plasmid system for tissue-specific and inducible control of gene expression in transgenic mice |